Department of Hepatobiliary and Pancreatic Surgery, Second Hospital of Jilin University, Changchun, 130041, China.
Jilin Engineering Laboratory for Translational Medicine of Hepatobiliary and Pancreatic Diseases, Changchun, 130041, China.
J Exp Clin Cancer Res. 2020 Nov 30;39(1):267. doi: 10.1186/s13046-020-01765-x.
Pancreatic cancer is one of the most malignant tumors worldwide, and pancreatic ductal adenocarcinoma is the most common type. In pancreatic cancer, glycolysis is the primary way energy is produced to maintain the proliferation, invasion, migration, and metastasis of cancer cells, even under normoxia. However, the potential molecular mechanism is still unknown. From this perspective, this review mainly aimed to summarize the current reasonable interpretation of aerobic glycolysis in pancreatic cancer and some of the newest methods for the detection and treatment of pancreatic cancer. More specifically, we reported some biochemical parameters, such as newly developed enzymes and transporters, and further explored their potential as diagnostic biomarkers and therapeutic targets.
胰腺癌是全球最恶性的肿瘤之一,其中胰腺导管腺癌最为常见。在胰腺癌中,即使在正常氧浓度下,糖酵解也是产生能量以维持癌细胞增殖、侵袭、迁移和转移的主要方式。然而,潜在的分子机制尚不清楚。从这个角度来看,本综述主要旨在总结目前对胰腺癌有氧糖酵解的合理解释,以及一些用于检测和治疗胰腺癌的最新方法。更具体地说,我们报告了一些生化参数,如新开发的酶和转运蛋白,并进一步探讨了它们作为诊断生物标志物和治疗靶点的潜力。